advertisement
Abstract #14304 Published in IGR 8-3
Compare of daily cost of ophthalmic solutions for glaucoma
Gao Y; Wu L-L; Li A-JOphthalmology in China 2006; 15: 127-129
OBJECTIVE: To determine and compare the daily cost of various ophthalmic solutions for glaucoma in China. DESIGH: Investigative study. PARTICIPANTS: The majority ophthalmic solutions for glaucoma available in our country were included in the research. METHODS: Five bottles of each solution were tested separately by five researchers. After the number of drops and the actual volume for each bottle were calculated, the mean number of drops per bottle and the mean volume per bottle were determined. The volume per drop was calculated by dividing the mean volume per bottle by the mean number of drops per bottle, and the cost per drop was calculated by dividing the market price by the mean number of drops in a bottle. The number of days for both eyes usage per bottle was calculated by dividing the mean number of drops in a bottle by the number of drops required daily for both eyes. The cost per day was calculated by multiplying the cost per drop by the number of drops required daily for both eyes. MAIN OUTCOME MEASURES: The number of days for both eyes usage per bottle and the daily cost for both eyes usage per bottle. RESULTS: 1. The volume per drop ranged from 0.027 ml (Lumigan) to 0.053 ml (Chengrui and 0.5% Zhenrui). 2. The cost per bottle ranged from 5.7 Yuan (Malaisuan Saimaluo'er) to 338 Yuan (Xalatan). 3. The number of days for both eyes usage per bottle ranged from 52d (Lumigan) to 12d (Zhenrui). 4. The daily cost for both eyes usage from expensive to cheap were Xalatan 7.51 Yuan, Travatan 6.30 Yuan, Lumigan 3.84 Yuan, Alphagan 3.36 Yuan, Dilijian 2.97 Yuan, Pailiming 2.83 Yuan, 2% Zhenrui 2.34 Yuan, Betagan 2.11 Yuan, Beiteshu 2.0 Yuan, 0.5% Zhenrui 1.49 Yuan, 2% Huming 1.29 Yuan, Mikelan 1.21 Yuan, 1% Huming 0.85 Yuan, Chengrai 0.63 Yuan, Malaisuan Saimaluo'er 0.23 Yuan. CONCLUSIONS: The daily cost of ophthalmic solution for glaucoma ranged wildly. These data may be useful in selecting ophthalmic solution for glaucoma therapy. LA: Chinese
Dr. L.-L. Wu, Peking University Eye Centre, Beijing 100083, China
Classification:
14 Costing studies; pharmacoeconomics
